Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Stohler

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Addiction (Abingdon, England)|November 11, 2010
Benzodiazepine dependence: when abstinence is not an optionMichael Liebrenz, Lukas Boesch, Rudolf Stohler, et al.
Addiction (Abingdon, England)|May 12, 2010
Agonist substitution--a treatment alternative for high-dose benzodiazepine-dependent patients?Michael Liebrenz, Lukas Boesch, Rudolf Stohler, et al.
Swiss Medical Weekly|May 26, 2007
Intravenous ketamine therapy in a patient with a treatment-resistant major depressionMichael Liebrenz, Alain Borgeat, Ria Leisinger, et al.
Substance Use & Misuse|December 17, 2008
Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers?Michael Schaub, Kyra Fanghaenel, Charlotte Senn, et al.
The American Journal on Addictions|August 16, 2011
Transdermal buprenorphine to switch patients from higher dose methadone to buprenorphine without severe withdrawal symptomsMelanie Hess, Lukas Boesch, Ria Leisinger, et al.
Psychiatrische Praxis|February 16, 2005
[For and against: cannabis]Michael Schaub, Kenneth Dürsteler-MacFarland, Rudolf Stohler, et al.
Swiss Medical Weekly|September 11, 2013
QTc prolongation in methadone maintenance--the role of HCV infectionNajibulah Gholami, Lukas Boesch, Luis Falcato, et al.
Journal of Medical Case Reports|May 16, 2012
High dose methylphenidate treatment in adult attention deficit hyperactivity disorder: a case reportMichael Liebrenz, Danielle Hof, Anna Buadze, et al.
Harm Reduction Journal|October 6, 2010
Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophreniaAnna Buadze, Rudolf Stohler, Beate Schulze, et al.
Journal of Clinical Epidemiology|June 16, 2015
A comprehensive model of treatment participation in chronic disease allowed prediction of opioid substitution treatment participation in Zurich, 1992-2012Carlos Nordt, Marc Vogel, Kenneth M Dürsteler, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Addiction (Abingdon, England)|November 11, 2010
Benzodiazepine dependence: when abstinence is not an optionMichael Liebrenz, Lukas Boesch, Rudolf Stohler, et al.
Addiction (Abingdon, England)|May 12, 2010
Agonist substitution--a treatment alternative for high-dose benzodiazepine-dependent patients?Michael Liebrenz, Lukas Boesch, Rudolf Stohler, et al.
Swiss Medical Weekly|May 26, 2007
Intravenous ketamine therapy in a patient with a treatment-resistant major depressionMichael Liebrenz, Alain Borgeat, Ria Leisinger, et al.
Substance Use & Misuse|December 17, 2008
Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers?Michael Schaub, Kyra Fanghaenel, Charlotte Senn, et al.
The American Journal on Addictions|August 16, 2011
Transdermal buprenorphine to switch patients from higher dose methadone to buprenorphine without severe withdrawal symptomsMelanie Hess, Lukas Boesch, Ria Leisinger, et al.
Psychiatrische Praxis|February 16, 2005
[For and against: cannabis]Michael Schaub, Kenneth Dürsteler-MacFarland, Rudolf Stohler, et al.
Swiss Medical Weekly|September 11, 2013
QTc prolongation in methadone maintenance--the role of HCV infectionNajibulah Gholami, Lukas Boesch, Luis Falcato, et al.
Journal of Medical Case Reports|May 16, 2012
High dose methylphenidate treatment in adult attention deficit hyperactivity disorder: a case reportMichael Liebrenz, Danielle Hof, Anna Buadze, et al.
Harm Reduction Journal|October 6, 2010
Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophreniaAnna Buadze, Rudolf Stohler, Beate Schulze, et al.
Journal of Clinical Epidemiology|June 16, 2015
A comprehensive model of treatment participation in chronic disease allowed prediction of opioid substitution treatment participation in Zurich, 1992-2012Carlos Nordt, Marc Vogel, Kenneth M Dürsteler, et al.
Pageof 4